Vivet Therapeutics raised €38M in a Series A round in May 2017. The company is based in Paris, France. Investors in the round: Columbus Venture Partners, HealthCap, Kurma Partners and 3 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €38M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
